Viewing StudyNCT00502671



Ignite Creation Date: 2024-05-05 @ 6:34 PM
Last Modification Date: 2024-10-26 @ 9:34 AM
Study NCT ID: NCT00502671
Status: COMPLETED
Last Update Posted: 2015-09-03
First Post: 2007-07-17

Brief Title: A Study of Xeloda Capecitabine as Adjuvant Monotherapy in Patients With Colon Cancer
Sponsor:
Organization: Hoffmann-La Roche